AustralieFrV1, PubMed, Corpus, bibRecord, 001F61

Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.

Identifieur interne : 001F61 ( PubMed/Corpus ); précédent : 001F60; suivant : 001F62

Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.

Auteurs : E M C. Driessen ; P. De Lorenzo ; M. Campbell ; M. Felice ; A. Ferster ; I. Hann ; A. Vora ; L. Hovi ; G. Escherich ; C K Li ; G. Mann ; T. Leblanc ; F. Locatelli ; A. Biondi ; J. Rubnitz ; M. Schrappe ; L. Silverman ; J. Stary ; R. Suppiah ; T. Szczepanski ; M. Valsecchi ; R. Pieters

Source :

Leukemia [ 1476-5551 ] ; 2016.

RBID : pubmed:26369984

English descriptors

KwdEn :
- Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Humans, Infant, Infant, Newborn, Precursor Cell Lymphoblastic Leukemia-Lymphoma (drug therapy), Precursor Cell Lymphoblastic Leukemia-Lymphoma (mortality), Recurrence, Treatment Outcome.
MESH :
- drug therapy : Precursor Cell Lymphoblastic Leukemia-Lymphoma.
- mortality : Precursor Cell Lymphoblastic Leukemia-Lymphoma.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- Humans, Infant, Infant, Newborn, Recurrence, Treatment Outcome.

DOI: 10.1038/leu.2015.246
PubMed: 26369984

Links to Exploration step

pubmed:26369984

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.</title>
<author><name sortKey="Driessen, E M C" sort="Driessen, E M C" uniqKey="Driessen E" first="E M C" last="Driessen">E M C. Driessen</name>
<affiliation><nlm:affiliation>Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="De Lorenzo, P" sort="De Lorenzo, P" uniqKey="De Lorenzo P" first="P" last="De Lorenzo">P. De Lorenzo</name>
<affiliation><nlm:affiliation>Interfant-99 Trial Data Center, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Campbell, M" sort="Campbell, M" uniqKey="Campbell M" first="M" last="Campbell">M. Campbell</name>
<affiliation><nlm:affiliation>Chilean National Pediatric Oncology Group, PINDA, Roberto del Rio Hospital, Universidad de Chile, Santiago, Chile.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Felice, M" sort="Felice, M" uniqKey="Felice M" first="M" last="Felice">M. Felice</name>
<affiliation><nlm:affiliation>Department of Pediatric Hematology/Oncology, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ferster, A" sort="Ferster, A" uniqKey="Ferster A" first="A" last="Ferster">A. Ferster</name>
<affiliation><nlm:affiliation>Department of Hemato-Oncology, Hôpital Unviversitaire des Enfants Reine Fabiola (ULB), Brussels, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hann, I" sort="Hann, I" uniqKey="Hann I" first="I" last="Hann">I. Hann</name>
<affiliation><nlm:affiliation>UK Children's Cancer Study Group, Great Ormond Street Hospital for Children, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vora, A" sort="Vora, A" uniqKey="Vora A" first="A" last="Vora">A. Vora</name>
<affiliation><nlm:affiliation>Department of Paediatric Haematology, Sheffield Children's Hospital, Sheffield, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hovi, L" sort="Hovi, L" uniqKey="Hovi L" first="L" last="Hovi">L. Hovi</name>
<affiliation><nlm:affiliation>Nordic Society of Paediatric Haematology and Oncology, University of Helsinki, Helsinki, Finland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Escherich, G" sort="Escherich, G" uniqKey="Escherich G" first="G" last="Escherich">G. Escherich</name>
<affiliation><nlm:affiliation>University Medical Center Hamburg-Eppendorf, Clinic of Pediatric Hematology and Oncology, Hamburg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, C K" sort="Li, C K" uniqKey="Li C" first="C K" last="Li">C K Li</name>
<affiliation><nlm:affiliation>Hong Kong Paediatric Haematology and Oncology Study Group, Prince of Wales Hospital, Hong Kong, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mann, G" sort="Mann, G" uniqKey="Mann G" first="G" last="Mann">G. Mann</name>
<affiliation><nlm:affiliation>St. Anna Children's Cancer Research Institute and St. Anna Children's Hospital, Department of Pediatrics, Medical University School, Vienna, Austria.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Leblanc, T" sort="Leblanc, T" uniqKey="Leblanc T" first="T" last="Leblanc">T. Leblanc</name>
<affiliation><nlm:affiliation>Departement of Pediatric Hematology, Hôpital Robert-Debré, Paris, fort he FRALLE group, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Locatelli, F" sort="Locatelli, F" uniqKey="Locatelli F" first="F" last="Locatelli">F. Locatelli</name>
<affiliation><nlm:affiliation>Associazione Italiana Ematologia Oncologia Pediatrica, Italy Bambino Gesù Children's Hospital, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Biondi, A" sort="Biondi, A" uniqKey="Biondi A" first="A" last="Biondi">A. Biondi</name>
<affiliation><nlm:affiliation>Associazione Italiana Ematologia Oncologia Pediatrica, Italy Bambino Gesù Children's Hospital, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rubnitz, J" sort="Rubnitz, J" uniqKey="Rubnitz J" first="J" last="Rubnitz">J. Rubnitz</name>
<affiliation><nlm:affiliation>St Jude Children's Research Hospital, Memphis, TN, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schrappe, M" sort="Schrappe, M" uniqKey="Schrappe M" first="M" last="Schrappe">M. Schrappe</name>
<affiliation><nlm:affiliation>Berlin-Frankfurt-Münster Study Group, Hannover, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Silverman, L" sort="Silverman, L" uniqKey="Silverman L" first="L" last="Silverman">L. Silverman</name>
<affiliation><nlm:affiliation>Dana-Farber Cancer Institute ALL Consortium, Boston, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stary, J" sort="Stary, J" uniqKey="Stary J" first="J" last="Stary">J. Stary</name>
<affiliation><nlm:affiliation>Czech Pediatric Haematology, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Suppiah, R" sort="Suppiah, R" uniqKey="Suppiah R" first="R" last="Suppiah">R. Suppiah</name>
<affiliation><nlm:affiliation>Australian and New Zealand Children's Haematology and Oncology Study Group, North Adelaide, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Szczepanski, T" sort="Szczepanski, T" uniqKey="Szczepanski T" first="T" last="Szczepanski">T. Szczepanski</name>
<affiliation><nlm:affiliation>Polish Pediatric Leukemia and Lymphoma Study Group, and Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice, Poland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Valsecchi, M" sort="Valsecchi, M" uniqKey="Valsecchi M" first="M" last="Valsecchi">M. Valsecchi</name>
<affiliation><nlm:affiliation>Interfant-99 Trial Data Center, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pieters, R" sort="Pieters, R" uniqKey="Pieters R" first="R" last="Pieters">R. Pieters</name>
<affiliation><nlm:affiliation>Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26369984</idno>
<idno type="pmid">26369984</idno>
<idno type="doi">10.1038/leu.2015.246</idno>
<idno type="wicri:Area/PubMed/Corpus">001F61</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F61</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.</title>
<author><name sortKey="Driessen, E M C" sort="Driessen, E M C" uniqKey="Driessen E" first="E M C" last="Driessen">E M C. Driessen</name>
<affiliation><nlm:affiliation>Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="De Lorenzo, P" sort="De Lorenzo, P" uniqKey="De Lorenzo P" first="P" last="De Lorenzo">P. De Lorenzo</name>
<affiliation><nlm:affiliation>Interfant-99 Trial Data Center, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Campbell, M" sort="Campbell, M" uniqKey="Campbell M" first="M" last="Campbell">M. Campbell</name>
<affiliation><nlm:affiliation>Chilean National Pediatric Oncology Group, PINDA, Roberto del Rio Hospital, Universidad de Chile, Santiago, Chile.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Felice, M" sort="Felice, M" uniqKey="Felice M" first="M" last="Felice">M. Felice</name>
<affiliation><nlm:affiliation>Department of Pediatric Hematology/Oncology, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ferster, A" sort="Ferster, A" uniqKey="Ferster A" first="A" last="Ferster">A. Ferster</name>
<affiliation><nlm:affiliation>Department of Hemato-Oncology, Hôpital Unviversitaire des Enfants Reine Fabiola (ULB), Brussels, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hann, I" sort="Hann, I" uniqKey="Hann I" first="I" last="Hann">I. Hann</name>
<affiliation><nlm:affiliation>UK Children's Cancer Study Group, Great Ormond Street Hospital for Children, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vora, A" sort="Vora, A" uniqKey="Vora A" first="A" last="Vora">A. Vora</name>
<affiliation><nlm:affiliation>Department of Paediatric Haematology, Sheffield Children's Hospital, Sheffield, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hovi, L" sort="Hovi, L" uniqKey="Hovi L" first="L" last="Hovi">L. Hovi</name>
<affiliation><nlm:affiliation>Nordic Society of Paediatric Haematology and Oncology, University of Helsinki, Helsinki, Finland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Escherich, G" sort="Escherich, G" uniqKey="Escherich G" first="G" last="Escherich">G. Escherich</name>
<affiliation><nlm:affiliation>University Medical Center Hamburg-Eppendorf, Clinic of Pediatric Hematology and Oncology, Hamburg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, C K" sort="Li, C K" uniqKey="Li C" first="C K" last="Li">C K Li</name>
<affiliation><nlm:affiliation>Hong Kong Paediatric Haematology and Oncology Study Group, Prince of Wales Hospital, Hong Kong, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mann, G" sort="Mann, G" uniqKey="Mann G" first="G" last="Mann">G. Mann</name>
<affiliation><nlm:affiliation>St. Anna Children's Cancer Research Institute and St. Anna Children's Hospital, Department of Pediatrics, Medical University School, Vienna, Austria.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Leblanc, T" sort="Leblanc, T" uniqKey="Leblanc T" first="T" last="Leblanc">T. Leblanc</name>
<affiliation><nlm:affiliation>Departement of Pediatric Hematology, Hôpital Robert-Debré, Paris, fort he FRALLE group, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Locatelli, F" sort="Locatelli, F" uniqKey="Locatelli F" first="F" last="Locatelli">F. Locatelli</name>
<affiliation><nlm:affiliation>Associazione Italiana Ematologia Oncologia Pediatrica, Italy Bambino Gesù Children's Hospital, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Biondi, A" sort="Biondi, A" uniqKey="Biondi A" first="A" last="Biondi">A. Biondi</name>
<affiliation><nlm:affiliation>Associazione Italiana Ematologia Oncologia Pediatrica, Italy Bambino Gesù Children's Hospital, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rubnitz, J" sort="Rubnitz, J" uniqKey="Rubnitz J" first="J" last="Rubnitz">J. Rubnitz</name>
<affiliation><nlm:affiliation>St Jude Children's Research Hospital, Memphis, TN, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schrappe, M" sort="Schrappe, M" uniqKey="Schrappe M" first="M" last="Schrappe">M. Schrappe</name>
<affiliation><nlm:affiliation>Berlin-Frankfurt-Münster Study Group, Hannover, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Silverman, L" sort="Silverman, L" uniqKey="Silverman L" first="L" last="Silverman">L. Silverman</name>
<affiliation><nlm:affiliation>Dana-Farber Cancer Institute ALL Consortium, Boston, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stary, J" sort="Stary, J" uniqKey="Stary J" first="J" last="Stary">J. Stary</name>
<affiliation><nlm:affiliation>Czech Pediatric Haematology, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Suppiah, R" sort="Suppiah, R" uniqKey="Suppiah R" first="R" last="Suppiah">R. Suppiah</name>
<affiliation><nlm:affiliation>Australian and New Zealand Children's Haematology and Oncology Study Group, North Adelaide, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Szczepanski, T" sort="Szczepanski, T" uniqKey="Szczepanski T" first="T" last="Szczepanski">T. Szczepanski</name>
<affiliation><nlm:affiliation>Polish Pediatric Leukemia and Lymphoma Study Group, and Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice, Poland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Valsecchi, M" sort="Valsecchi, M" uniqKey="Valsecchi M" first="M" last="Valsecchi">M. Valsecchi</name>
<affiliation><nlm:affiliation>Interfant-99 Trial Data Center, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pieters, R" sort="Pieters, R" uniqKey="Pieters R" first="R" last="Pieters">R. Pieters</name>
<affiliation><nlm:affiliation>Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Leukemia</title>
<idno type="eISSN">1476-5551</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Precursor Cell Lymphoblastic Leukemia-Lymphoma (drug therapy)</term>
<term>Precursor Cell Lymphoblastic Leukemia-Lymphoma (mortality)</term>
<term>Recurrence</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Recurrence</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26369984</PMID>
<DateCreated><Year>2016</Year>
<Month>05</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>09</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5551</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>30</Volume>
<Issue>5</Issue>
<PubDate><Year>2016</Year>
<Month>05</Month>
</PubDate>
</JournalIssue>
<Title>Leukemia</Title>
<ISOAbbreviation>Leukemia</ISOAbbreviation>
</Journal>
<ArticleTitle>Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.</ArticleTitle>
<Pagination><MedlinePgn>1184-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/leu.2015.246</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Driessen</LastName>
<ForeName>E M C</ForeName>
<Initials>EM</Initials>
<AffiliationInfo><Affiliation>Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>de Lorenzo</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Interfant-99 Trial Data Center, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Campbell</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Chilean National Pediatric Oncology Group, PINDA, Roberto del Rio Hospital, Universidad de Chile, Santiago, Chile.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Felice</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Pediatric Hematology/Oncology, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ferster</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Hemato-Oncology, Hôpital Unviversitaire des Enfants Reine Fabiola (ULB), Brussels, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hann</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>UK Children's Cancer Study Group, Great Ormond Street Hospital for Children, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vora</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Paediatric Haematology, Sheffield Children's Hospital, Sheffield, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hovi</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Nordic Society of Paediatric Haematology and Oncology, University of Helsinki, Helsinki, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Escherich</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>University Medical Center Hamburg-Eppendorf, Clinic of Pediatric Hematology and Oncology, Hamburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>C K</ForeName>
<Initials>CK</Initials>
<AffiliationInfo><Affiliation>Hong Kong Paediatric Haematology and Oncology Study Group, Prince of Wales Hospital, Hong Kong, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mann</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>St. Anna Children's Cancer Research Institute and St. Anna Children's Hospital, Department of Pediatrics, Medical University School, Vienna, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Leblanc</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Departement of Pediatric Hematology, Hôpital Robert-Debré, Paris, fort he FRALLE group, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Locatelli</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Associazione Italiana Ematologia Oncologia Pediatrica, Italy Bambino Gesù Children's Hospital, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Biondi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Associazione Italiana Ematologia Oncologia Pediatrica, Italy Bambino Gesù Children's Hospital, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rubnitz</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>St Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schrappe</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Berlin-Frankfurt-Münster Study Group, Hannover, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Silverman</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Dana-Farber Cancer Institute ALL Consortium, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stary</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Czech Pediatric Haematology, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Suppiah</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Australian and New Zealand Children's Haematology and Oncology Study Group, North Adelaide, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Szczepanski</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Polish Pediatric Leukemia and Lymphoma Study Group, and Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Valsecchi</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Interfant-99 Trial Data Center, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pieters</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Dutch Childhood Oncology Group, The Hague, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>09</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Leukemia</MedlineTA>
<NlmUniqueID>8704895</NlmUniqueID>
<ISSNLinking>0887-6924</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 May 10;28(14):2339-47</RefSource>
<PMID Version="1">20385996</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pediatr Blood Cancer. 2009 Jul;52(7):808-13</RefSource>
<PMID Version="1">19229974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 1999 Aug 15;94(4):1209-17</RefSource>
<PMID Version="1">10438708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Oct 14;116(15):2644-50</RefSource>
<PMID Version="1">20592248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2012 Apr;26(4):682-92</RefSource>
<PMID Version="1">22015773</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2015 Feb;29(2):290-6</RefSource>
<PMID Version="1">24888273</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2014 Apr;28(4):761-9</RefSource>
<PMID Version="1">23958920</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2007 Jul 21;370(9583):240-50</RefSource>
<PMID Version="1">17658395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2008 Dec;22(12):2142-50</RefSource>
<PMID Version="1">18818707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2004 Dec 1;104(12):3527-34</RefSource>
<PMID Version="1">15297313</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2011 Jul 12;20(1):53-65</RefSource>
<PMID Version="1">21741596</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Apr 1;82(7):1387-95</RefSource>
<PMID Version="1">9529033</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Jan 10;29(2):214-22</RefSource>
<PMID Version="1">21135279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Haematologica. 2013 Jun;98(6):937-44</RefSource>
<PMID Version="1">23403319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2006 Aug;20(8):1368-76</RefSource>
<PMID Version="1">16761017</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054198" MajorTopicYN="N">Precursor Cell Lymphoblastic Leukemia-Lymphoma</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>9</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>9</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>9</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26369984</ArticleId>
<ArticleId IdType="pii">leu2015246</ArticleId>
<ArticleId IdType="doi">10.1038/leu.2015.246</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F61 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001F61 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:26369984
   |texte=   Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:26369984" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.

Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki